[1]
M. Bersanelli, “Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab”, Acta Biomed, vol. 90, no. 4, pp. 468–474, Dec. 2019, doi: 10.23750/abm.v90i4.7057.